
MRNA Stock Rose 2.51% as Moderna Chairman Said They Will Share Only Accurate Vaccine Data
Moderna chairman Noubar Afeyan assured people of the company’s fidelity to statistical accuracy concerning its vaccine trials. MRNA stock price went up yesterday.